Phase I Study of Photodynamic Therapy Using Pulsed Dye Laser and Oral Aminolevulinic Acid in Patients With Oral Leukoplakia
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2014
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Leucoplakia; Oropharyngeal cancer
- Focus Adverse reactions
- 10 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 May 2010 Planned end date changed from Dec 2008 to Jun 2013 as reported by ClinicalTrials.gov.
- 29 Jan 2010 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.